[April Dream] 'I'm glad NIPP was there' — Delivering treatment options that anyone can choose for pelvic cancer
MedCuration Co., Ltd. has announced its vision as part of 'April Dream' to create a society where 'NIPP,' a catheter treatment for pelvic cancer, is available to all patients in need. NIPP aims to provide a high-concentration drug delivery system with fewer side effects.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 20:02
- 🔍 Collected: April 1, 2026 at 16:47
- 🤖 AI Analyzed: April 21, 2026 at 17:19 (480h 32m after Collected)
MedCuration Co., Ltd. (Headquarters: Shizuoka Prefecture; CEO: Tomohiro Shibagaki) is pleased to announce our vision for the future as part of the 'April Dream' initiative on April 1, 2026: 'A society where the catheter treatment "NIPP" for pelvic cancer is available to all patients who need it.' In this article, we will share information about the NIPP treatment method, the people striving to deliver this treatment, and the path we intend to take in the future.
## What is Pelvic Cancer?
Pelvic cancers, including uterine cancer, bladder cancer, and rectal cancer, are diagnosed in approximately 110,000 people annually in Japan, and more than 30,000 patients lose their lives to these diseases. Depending on the stage of progression or recurrence, treatment options can be limited, making this a field with significant physical, economic, and psychological burdens for patients.
## About the NIPP Treatment Method
NIPP (Non-equilibrium Intrapelvic Perfusion) is a catheter-based treatment for pelvic cancer. A thin tube (catheter) with a diameter of 3 to 4 mm is inserted from the base of both legs, and blood flow within the pelvis is temporarily isolated using balloons. After delivering high concentrations of anticancer drugs exclusively to the pelvis, the drugs are recovered from the body. Clinical studies have reported that drug concentrations in the pelvis can reach more than 15 to 25 times that of conventional systemic chemotherapy (*Ref. 1). Because the system is designed to recover the drug after administration, leakage into the rest of the body is suppressed, leading to expectations of reduced side effects. The hospital stay for one treatment session is approximately five days. Treatment is usually completed in two sessions with an interval of about one month. It is said to be applicable even for patients with limited options, such as those with recurrence or progression after standard treatment.
## What is Pelvic Cancer?
Pelvic cancers, including uterine cancer, bladder cancer, and rectal cancer, are diagnosed in approximately 110,000 people annually in Japan, and more than 30,000 patients lose their lives to these diseases. Depending on the stage of progression or recurrence, treatment options can be limited, making this a field with significant physical, economic, and psychological burdens for patients.
## About the NIPP Treatment Method
NIPP (Non-equilibrium Intrapelvic Perfusion) is a catheter-based treatment for pelvic cancer. A thin tube (catheter) with a diameter of 3 to 4 mm is inserted from the base of both legs, and blood flow within the pelvis is temporarily isolated using balloons. After delivering high concentrations of anticancer drugs exclusively to the pelvis, the drugs are recovered from the body. Clinical studies have reported that drug concentrations in the pelvis can reach more than 15 to 25 times that of conventional systemic chemotherapy (*Ref. 1). Because the system is designed to recover the drug after administration, leakage into the rest of the body is suppressed, leading to expectations of reduced side effects. The hospital stay for one treatment session is approximately five days. Treatment is usually completed in two sessions with an interval of about one month. It is said to be applicable even for patients with limited options, such as those with recurrence or progression after standard treatment.